Search results for: 'cancer cell analyst'

This research report reviews the present scenario of the stationary fuel cells market in Europe, as well forecast commercialisation, future revenues, installed capacity and unit sales of the stationary fuel cell systems. It identifies key market drivers, market restraints as well as challenges facing the industry, evaluates and translates them into...

This research service analyzes the market for cell-based assays within the United States. This market was divided into three segments, covering cell growth-associated assays, cell death-associated assays, and functional cell assays. Each segment of this service provides an overview, analysis of products available, revenue forecasts, and market sh...

Greener energy sources are being favored globally due to the emissions of large amounts of hazardous particles from the conventional power sources. Fuel cells, wind turbines, and solar panels are amongst the energy sources being looked towards offering cleaner, efficient power to the end users. With the growing initiatives by the Indian Government,...

Although artificial intelligence (AI) has been around for decades, and the contact center industry has been leveraging it for years, recent advancements in AI have rapidly accelerated. The latter half of 2024 spouted industry excitement for next-level GenAI - agentic AI, also sometimes called autonomous AI. Agentic AI can act as the glue for orches...

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient product...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including Interventional rad...